Related Experiment Video
Updated: Jul 21, 2025
06:59
Improved Registration of 3D CT Angiography with X-ray Fluoroscopy for Image Fusion During Transcatheter Aortic Valve Implantation
Published on: June 3, 2018
10.7K
Association of Depression and Cognitive Dysfunction With Patient-Centered Outcomes After Transcatheter Aortic Valve
Bassim El-Sabawi1, Harrison Cloud1, Jay N Patel1
1Department of Medicine, Division of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, TN (B.E.-S., H.C., J.N.P., S.P.B., R.N.P., A.V., N.J., B.R.L.).
Circulation. Cardiovascular Interventions
|July 28, 2023
Summary
Depression and cognitive dysfunction are common in patients undergoing transcatheter aortic valve replacement (TAVR). These conditions increase mortality risk and worsen quality of life, suggesting depression may be a target for improved TAVR outcomes.
Area of Science:
- Cardiology
- Psychiatry
- Geriatrics
Background:
- Depression and cognitive dysfunction (CD) are not routinely assessed before transcatheter aortic valve replacement (TAVR).
- The impact of these conditions on post-TAVR outcomes is not well understood.
Purpose of the Study:
- To determine the prevalence of depression and CD in patients undergoing TAVR.
- To evaluate the association of depression and CD with mortality and quality of life after TAVR.
Main Methods:
- Analysis of a prospective, multicenter TAVR registry.
- Systematic screening for depression (Patient Health Questionnaire-2) and CD (Mini-Cog) at baseline.
- Cox proportional hazard models for mortality and multivariable ordinal regression for quality of life (Kansas City Cardiomyopathy Questionnaire, EuroQol visual analogue scale).
Main Results:
- 19.6% of 884 patients had depression, and 31.8% had CD at baseline.
- Both depression (HR, 1.45) and CD (HR, 1.27) were independently associated with increased mortality.
- Patients with both depression and CD had the highest mortality risk (HR, 2.06).
- Depression was linked to significantly lower quality of life scores post-TAVR.
Conclusions:
- Depression and CD are prevalent in TAVR patients and linked to worse outcomes.
- Targeting depression could be a modifiable strategy to enhance post-TAVR results.
Related Concept Videos
01:25Cognitive Therapy
178
Cognitive therapy, pioneered by Aaron T. Beck in the 1960s, is a structured approach to addressing psychological distress by focusing on the influence of thoughts on emotions and behaviors. All cognitive therapies involve the basic assumption that human beings have control over their feelings, and that how individuals feel about something depends on how they think about it. Unlike psychoanalytic methods that delve into unconscious processes or humanistic approaches emphasizing...
178
01:30Acute Coronary Syndrome III: Diagnostic Studies
10
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
10
01:27Coronary Artery Disease V: Interprofessional Care
9
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
9
01:22Mitral Valve Prolapse II: Assessment and Management
23
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
23
01:28Acute Coronary Syndrome IV: Interprofessional Care
12
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
12
01:21Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
17
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
17